These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 8784662)

  • 21. The treatment of psychogenic excoriation and obsessive compulsive disorder using aripiprazole and fluoxetine.
    Curtis AR; Richards RW
    Ann Clin Psychiatry; 2007; 19(3):199-200. PubMed ID: 17729023
    [No Abstract]   [Full Text] [Related]  

  • 22. Possible case of quetiapine-induced rhabdomyolysis in a patient with depression treated with fluoxetine.
    Himmerich H; Ehrlinger M; Hackenberg M; Löhr B; Nickel T
    J Clin Psychopharmacol; 2006 Dec; 26(6):676-7. PubMed ID: 17110835
    [No Abstract]   [Full Text] [Related]  

  • 23. Geriatric dysthymia.
    Kocsis JH
    J Clin Psychiatry; 1998; 59 Suppl 10():13-5. PubMed ID: 9720477
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pilot study of haloperidol, fluoxetine, and placebo for agitation in Alzheimer's disease.
    Auchus AP; Bissey-Black C
    J Neuropsychiatry Clin Neurosci; 1997; 9(4):591-3. PubMed ID: 9447502
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Risperidone for exclusively negative symptoms.
    Lane HY; Liu CC; Chang WH
    Am J Psychiatry; 1999 Feb; 156(2):335. PubMed ID: 9989576
    [No Abstract]   [Full Text] [Related]  

  • 26. Open trial study of a combined antidepressant (amitryptiline, perphenazine, diazepam) versus fluoxetine or imipramine in ambulatory depressed patients.
    Diaz A; Fouilloux C; Ortiz S
    Proc West Pharmacol Soc; 2002; 45():154-5. PubMed ID: 12434564
    [No Abstract]   [Full Text] [Related]  

  • 27. An open trial of paroxetine in the treatment of children and adolescents diagnosed with dysthymia.
    Nobile M; Bellotti B; Marino C; Molteni M; Battaglia M
    J Child Adolesc Psychopharmacol; 2000; 10(2):103-9. PubMed ID: 10933120
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Augmentation of milnacipran by risperidone in treatment for major depression.
    Tani K; Takei N; Kawai M; Suzuki K; Sekine Y; Toyoda T; Minabe Y; Mori N
    Int J Neuropsychopharmacol; 2004 Mar; 7(1):55-8. PubMed ID: 14731310
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Carbamazepine and/or fluvoxamine drug interaction with risperidone in a patient on multiple psychotropic medications.
    Alfaro CL; Nicolson R; Lenane M; Rapoport JL
    Ann Pharmacother; 2000 Jan; 34(1):122-3. PubMed ID: 10669197
    [No Abstract]   [Full Text] [Related]  

  • 30. Prescribing patterns of psychotropic medications and clinical features in patients with major depressive disorder with and without comorbid dysthymia in China.
    Feng Y; Sha S; Hu C; Wang G; Ungvari GS; Chiu HF; Ng CH; Si TM; Chen DF; Fang YR; Lu Z; Yang HC; Hu J; Chen ZY; Huang Y; Sun J; Wang XP; Li HC; Zhang JB; Xiang YT
    Asia Pac Psychiatry; 2017 Mar; 9(1):. PubMed ID: 27759189
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Successful treatment of tuberous sclerosis with psychosis and obsessive-compulsive disorder: A case report.
    Rao SA; Rao MG; Rao NP; Varambally S; Gangadhar BN
    Psychiatry Clin Neurosci; 2015 Aug; 69(8):504-5. PubMed ID: 25907259
    [No Abstract]   [Full Text] [Related]  

  • 32. Should the Physician's Desk Reference contraindicate the use of chlorpromazine-fluoxetine combination? A case report.
    Adetunji B; Basil B; Mathews M; Osinowo T
    J Clin Psychopharmacol; 2006 Aug; 26(4):438. PubMed ID: 16855470
    [No Abstract]   [Full Text] [Related]  

  • 33. Fluoxetine treatment of depressed patients with comorbid anxiety disorders.
    Sonawalla SB; Farabaugh A; Johnson MW; Morray M; Delgado ML; Pingol MG; Rosenbaum JF; Fava M
    J Psychopharmacol; 2002 Sep; 16(3):215-9. PubMed ID: 12236627
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dysthymic disorder: treatment with citalopram.
    Dunner DL; Hendricksen HE; Bea C; Budech CB; Friedman SD
    Depress Anxiety; 2002; 15(1):18-22. PubMed ID: 11816048
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Therapeutic and pharmacological effects of second-generation antipsychotics on drug-resistant bipolar depression].
    Kuroki T; Kaminiwa S; Haeno M; Kohara K; Ninomiya H
    Seishin Shinkeigaku Zasshi; 2004; 106(8):1025-9. PubMed ID: 15655899
    [No Abstract]   [Full Text] [Related]  

  • 36. Quetiapine resolves psychotic depression in an adolescent boy.
    Padla D
    J Child Adolesc Psychopharmacol; 2001; 11(2):207-8. PubMed ID: 11436964
    [No Abstract]   [Full Text] [Related]  

  • 37. Open-label evaluation of venlafaxine sustained release in outpatients with generalized anxiety disorder with comorbid major depression or dysthymia: effectiveness, tolerability and predictors of response.
    Perugi G; Frare F; Toni C; Ruffolo G; Torti C
    Neuropsychobiology; 2002; 46(3):145-9. PubMed ID: 12422062
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Treatment of dysthymic disorder.
    Dunner DL
    Depress Anxiety; 1998; 8 Suppl 1():54-8. PubMed ID: 9809214
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Urinary retention caused after fluoxetine-risperidone combination.
    Bozikas V; Petrikis P; Karavatos A
    J Psychopharmacol; 2001 Jun; 15(2):142-3. PubMed ID: 11448089
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Interaction between fluoxetine and haloperidol: pharmacokinetic and clinical implications.
    Avenoso A; Spinà E; Campo G; Facciolă G; Ferlito M; Zuccaro P; Perucca E; Caputi AP
    Pharmacol Res; 1997 Apr; 35(4):335-9. PubMed ID: 9264051
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.